---
format: html
toc: true
toc-location: right
---
### Peer-Reviewed Literature


[Replacing the Gleason score with pattern 4 quantification](https://pubmed.ncbi.nlm.nih.gov/32304682/){target="_blank"}

### Pattern 4 Quantification: Prognostic Papers

- [Length of pattern 4 predicts adverse surgical pathology in men with grade group 2 prostate cancer](https://pubmed.ncbi.nlm.nih.gov/30076908/){target="_blank"}
  <br><span style="font-size:0.95em;">Dean LW, Assel M, Sjoberg DD, et al. Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer. J Urol. 2019;202(2):309-316. doi:10.1016/j.juro.2018.07.062</span>
- [Length of pattern 4 predicts biochemical recurrence in men with grade group 2 prostate cancer](https://pubmed.ncbi.nlm.nih.gov/35363038/){target="_blank"}
  <br><span style="font-size:0.95em;">Perera M, Assel MJ, Benfante NE, et al. Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer. J Urol. 2022;208(2):309-316. doi:10.1097/JU.0000000000002685</span>
- [Pattern 4 in men on active surveillance: upgrading a questionable endpoint](https://pubmed.ncbi.nlm.nih.gov/40301553/){target="_blank"}
  <br><span style="font-size:0.95em;">Uleri A, Baboudjian M, Leni R, et al. Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer. Prostate Cancer Prostatic Dis. 2024. doi:10.1038/s41391-025-00977-6</span>
- [Pattern 4 volume best predictor of PSA](https://pubmed.ncbi.nlm.nih.gov/39977387/){target="_blank"}
  <br><span style="font-size:0.95em;">Scuderi S, Tin AL, Klug J, et al. The Absolute Volume of Gleason Pattern 4 on Radical Prostatectomy Is More Strongly Associated With Advanced Stage and Biochemical Recurrence Than Gleason Grade Groups. J Urol. 2024. doi:10.1097/JU.0000000000004484</span>
- [Pattern 4 volume best predictor of advanced pathologic stage](https://pubmed.ncbi.nlm.nih.gov/39977387/){target="_blank"}
  <br><span style="font-size:0.95em;">Scuderi S, Tin AL, Klug J, et al. The Absolute Volume of Gleason Pattern 4 on Radical Prostatectomy Is More Strongly Associated With Advanced Stage and Biochemical Recurrence Than Gleason Grade Groups. J Urol. 2024. doi:10.1097/JU.0000000000004484</span>
- [Pattern 4 and 5 volume best predictor of distant metastasis](https://pubmed.ncbi.nlm.nih.gov/32171650/){target="_blank"}
  <br><span style="font-size:0.95em;">Acosta AM, Taplin ME, Mata DA, et al. Volume of Gleason pattern 4 stratifies risk of metastasis and death in patients with Gleason score 3+5=8/5+3=8 positive prostate core biopsies. Hum Pathol. 2020;101:80-87. doi:10.1016/j.humpath.2020.03.001</span>

---

### Papers where the results are best explained by pattern 4 volume being prognostic

- [Tumor volume assessed on MRI prognostic](https://pubmed.ncbi.nlm.nih.gov/39470422/){target="_blank"}
  <br><span style="font-size:0.95em;">Yang DD, Lee LK, Tsui JMG, Leeman JE, McClure HM, Sudhyadhom A, Guthier CV, Taplin ME, Trinh QD, Mouw KW, Martin NE, Orio PF, Nguyen PL, D'Amico AV, Shin KY, Lee KN, King MT. AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer. Radiology. 2024 Oct;313(1):e240041. doi: 10.1148/radiol.240041. PMID: 39470422.</span>
- [Clinical low risk cancer at low risk of recurrence even if upgraded at radical prostatectomy](https://pubmed.ncbi.nlm.nih.gov/34319588/){target="_blank"}<br><span style="font-size:0.95em;">Zhen L, Zhien Z, Shengmin Y, Hanzhong L, Xingcheng W, Yi Z, Yi Q, Lin M, Yuliang C, Tianrui F, Weigang Y. Can patients with low-risk prostate cancer really benefit from radical treatment?: A systematic review and network meta-analysis. Andrologia. 2021 Oct;53(9):e14122. doi: 10.1111/and.14122. Epub 2021 Jul 28. PMID: 34319588.</span>
- [Clinical low risk cancer at low risk of metastasis even if upgraded at radical prostatectomy](https://pubmed.ncbi.nlm.nih.gov/29802773/){target="_blank"}<br><span style="font-size:0.95em;">Kovac E, Vertosick EA, Sjoberg DD, Vickers AJ, Stephenson AJ. Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer. BJU Int. 2018 Dec;122(6):1003-1009. doi: 10.1111/bju.14418. Epub 2018 Jun 22. PMID: 29802773; PMCID: PMC6737926. </span>
- [MRI finds tumors in men with negative biopsy that are not aggressive](https://pubmed.ncbi.nlm.nih.gov/39666360/){target="_blank"}
  <br><span style="font-size:0.95em;"></span>
 

---

### Variation in Pattern 4 Quantification

- [Variability in tumor extent by different pathologists](https://pubmed.ncbi.nlm.nih.gov/39610035/){target="_blank"}
- [Variability in pattern 4 volume between pathologists at two separate institutions](https://pubmed.ncbi.nlm.nih.gov/32815034/){target="_blank"}

---

### Papers: pattern 3 is indolent and does not add prognostic value once amount of pattern 4 is known

- [Pattern 3 non-predictive of PSA or advanced surgical pathology once pattern 4 is known](https://pubmed.ncbi.nlm.nih.gov/38278665/){target="_blank"}
- [Pattern 3 volume does not add to pattern 4 volume to predict advanced pathologic stage](https://pubmed.ncbi.nlm.nih.gov/39977387/){target="_blank"}

- [Pattern 4 and 5 volume best predictor of distant metastasis](https://pubmed.ncbi.nlm.nih.gov/32171650/){target="_blank"}

---

### Papers where the results are best explained by pattern 4 volume being prognostic

- [Tumor volume assessed on MRI prognostic](https://pubmed.ncbi.nlm.nih.gov/39470422/){target="_blank"}
- [Clinical low risk cancer at low risk of recurrence even if upgraded at radical prostatectomy](https://pubmed.ncbi.nlm.nih.gov/34319588/){target="_blank"}
- [Clinical low risk cancer at low risk of metastasis even if upgraded at radical prostatectomy](https://pubmed.ncbi.nlm.nih.gov/35838831/){target="_blank"}
- [MRI finds tumors in men with negative biopsy that are not aggressive](https://www.sciencedirect.com/science/article/abs/pii/S0302283821018674?via%3Dihub){target="_blank"}

---

### Variation between pathologists in pattern 4 quantification

- [Variability in tumor extent by different pathologists](https://pubmed.ncbi.nlm.nih.gov/39610035/){target="_blank"}
- [Variability in pattern 4 volume between pathologists at two separate institutions](https://pubmed.ncbi.nlm.nih.gov/32815034/){target="_blank"}

---

### Pattern 3: Indolent When Pattern 4 Known


- [Pattern 3 non-predictive of PSA or advanced surgical pathology once pattern 4 is known](https://pubmed.ncbi.nlm.nih.gov/38278665/){target="_blank"}
- [Pattern 3 volume does not add to pattern 4 volume to predict advanced pathologic stage](https://pubmed.ncbi.nlm.nih.gov/39977387/){target="_blank"}